-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one is a complex and multi-step process that involves several chemical reactions and intermediate products.
The final product is a highly sought-after pharmaceutical ingredient, and its synthesis requires careful planning, execution, and optimization to ensure its quality and purity.
One of the most common synthetic routes for 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one begins with the synthesis of a starting material called 2-bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9(10H)-one.
This compound can be synthesized using several methods, including the reaction of 2-bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9(10H)-one with a Grignard reagent, followed by hydrolysis of the resulting intermediate with a strong base such as sodium hydroxide.
Once the starting material has been synthesized, the next step is to convert it into 2-bromo-8-fluoro-5,6-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one.
This can be accomplished by using a reagent such as potassium fluoride, which will react with the starting material to form the desired bromide.
The next step is to reduce the nitro group of the intermediate compound to form the corresponding amine.
This can be accomplished using a reducing agent such as lithium aluminum hydride (LAH) or diisobutylaluminum hydride (DIBAL-H) in anhydrous ether or THF.
The final step in the synthesis of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one is to convert the primary amine into the desired indole via a condensation reaction with an appropriate carbonyl compound, such as acetyl chloride.
Overall, the synthesis of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one requires careful planning and execution, as well as a good understanding of the underlying chemical reactions and their optimization.
The process may also involve several purification steps to remove any impurities and ensure the purity of the final product.
The quality and purity of the final product are critical for its use as a pharmaceutical ingredient, and therefore must be carefully controlled throughout the synthesis process.
